Literature DB >> 8168505

Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex.

A A Kortt1, R L Malby, J B Caldwell, L C Gruen, N Ivancic, M C Lawrence, G J Howlett, R G Webster, P J Hudson, P M Colman.   

Abstract

The single-chain antibody variable fragment (scFv), with a 15-residue polypeptide linker (Gly4Ser)3, of monoclonal antibody NC10 was expressed in Escherichia coli and purified to homogeneity. This scFv molecule, refolded from 6 M guanidine hydrochloride, was predominantly a monomer of 27 kDa and was stable on storage at 4 degrees and 20 degrees C. At higher protein concentrations (approximately 5 mg/ml) dimer and higher-molecular-mass multimers were formed and freezing enhanced this aggregation. The dimer was not stable and dissociated to monomer at 20 degrees C with a half-life of approximately 8 days. The higher-molecular-mass multimers and dimer dissociated to monomer in 60% ethylene glycol. Both the monomer and dimer were active and with tern N9 sialidase yielded complexes of 276 kDa and 569 kDa, respectively, indicating that four scFv molecules bound/sialidase tetramer and that the dimer was bivalent and cross-linked two sialidase tetramers. Binding studies at low concentrations and using radiolabelled scFv indicated that the binding affinity of the dimer was approximately twofold higher than that of the monomer, and the binding affinities of the scFv were similar to that of the parent NC10 antigen-binding fragment (Fab) molecule. A complex between tern N9 sialidase and NC10 scFv was crystallized and the structure of the complex was solved at 0.3-nm resolution by X-ray diffraction. Comparison of this scFv/sialidase structure with the parent Fab/sialidase structure revealed that the modes of attachment of scFv and Fab to sialidase were very similar. There was no discernible electron density for the peptide linker joining the variable heavy (VH) and variable light (VL) chains. A close interaction between two symmetry-related scFv suggests that they may have crystallized as dimers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168505     DOI: 10.1111/j.1432-1033.1994.tb18724.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  28 in total

1.  Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues.

Authors:  F Rousseau; J W Schymkowitz; H R Wilkinson; L S Itzhaki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 2.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

3.  Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors:  Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

Review 4.  Antibody-enabled small-molecule drug discovery.

Authors:  Alastair D G Lawson
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

5.  Anti-CHMP5 single chain variable fragment antibody retrovirus infection induces programmed cell death of AML leukemic cells in vitro.

Authors:  Hai-rong Wang; Zhen-yu Xiao; Miao Chen; Fei-long Wang; Jia Liu; Hua Zhong; Ji-hua Zhong; Ren-rong Ou-Yang; Yan-lin Shen; Shu-ming Pan
Journal:  Acta Pharmacol Sin       Date:  2012-05-21       Impact factor: 6.150

6.  Role of dimerization in the catalytic properties of the Escherichia coli disulfide isomerase DsbC.

Authors:  Silvia A Arredondo; Tiffany F Chen; Austen F Riggs; Hiram F Gilbert; George Georgiou
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

Review 7.  Antibody fragments as tools in crystallography.

Authors:  L Griffin; A Lawson
Journal:  Clin Exp Immunol       Date:  2011-06-07       Impact factor: 4.330

8.  Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.

Authors:  Jennifer B Treweek; Amanda J Roberts; Kim D Janda
Journal:  Pharmacol Biochem Behav       Date:  2011-02-26       Impact factor: 3.533

Review 9.  3D domain swapping: a mechanism for oligomer assembly.

Authors:  M J Bennett; M P Schlunegger; D Eisenberg
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

10.  ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

Authors:  Tove Olafsen; Shannon J Sirk; David J Betting; Vania E Kenanova; Karl B Bauer; Waldemar Ladno; Andrew A Raubitschek; John M Timmerman; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2010-01-06       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.